Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Total Non-Current Liabilities: 2015-2024

Historic Total Non-Current Liabilities for Wave Life Sciences (WVE) over the last 10 years, with Dec 2024 value amounting to $23.9 million.

  • Wave Life Sciences' Total Non-Current Liabilities fell 39.73% to $23.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.1 million, marking a year-over-year decrease of 39.73%. This contributed to the annual value of $23.9 million for FY2024, which is 41.80% down from last year.
  • Latest data reveals that Wave Life Sciences reported Total Non-Current Liabilities of $23.9 million as of FY2024, which was down 41.80% from $41.0 million recorded in FY2023.
  • In the past 5 years, Wave Life Sciences' Total Non-Current Liabilities ranged from a high of $112.1 million in FY2022 and a low of $23.9 million during FY2024.
  • For the 3-year period, Wave Life Sciences' Total Non-Current Liabilities averaged around $59.0 million, with its median value being $41.0 million (2023).
  • Per our database at Business Quant, Wave Life Sciences' Total Non-Current Liabilities skyrocketed by 51.65% in 2021 and then plummeted by 63.42% in 2023.
  • Yearly analysis of 5 years shows Wave Life Sciences' Total Non-Current Liabilities stood at $67.5 million in 2020, then surged by 51.65% to $102.4 million in 2021, then grew by 9.42% to $112.1 million in 2022, then plummeted by 63.42% to $41.0 million in 2023, then plummeted by 41.80% to $23.9 million in 2024.